Skip to main content
. 2022 Jun 4;23:145. doi: 10.1186/s12875-022-01746-3

Table 1.

Characteristics of all study participants at baseline and missing study participants at T5

Intervention
n = 77
Intervention missing T5
n = 18 (23%)
Control
n = 77
Control missing T5
n = 8 (10%)
Female n (%) 57 (74.0) 13 (72.2) 58 (75.3) 6 (75.0)
Age mean (±SD) 61.8 (11.4) 64 (9.5) 59.3 (12.2) 62 (11.9)
Cancer type n (%)
 Breast 38 (49.4) 8 (44.4) 40 (51.9) 4 (50.0)
 Colorectal 20 (26.0) 6 (33.3) 18 (23.4) 1 (12.5)
 Melanoma 13 (16.9) 2 (11.1) 11 (14.3) 1 (12.5)
 Gynaecologic 3 (3.9) 2 (11.1) 2 (2.6) 2 (25.0)
 Lung 3 (3.9) 6 (7.8)
Hospital setting n (%)
 Academic 22 (28.6) 7 (38.9) 24 (31.2) 2 (25)
 Non academic 55 (71.4) 11 (61.1) 53 (68.8) 6 (75)
Cancer stage1
 0 2 (2.6) 2 (2.6)
 I 34 (44.2) 6 (33.3) 34 (44.2) 5 (62.5)
 II 22 (28.6) 5 (27.8) 27 (35.1) 3 (37.5)
 III 18 (23.4) 6 (33.3) 14 (18.2)
 IV 1 (1.3) 1 (5.6)
Education
 Low 32 (41.6) 9 (50) 25 (32.5) 1 (12.5)
 Middle 13 (16.9) 1 (5.6) 18 (23.4) 4 (50.0)
 High 32 (41.6) 8 (44.4) 34 (44.2) 3 (37.5)
Number of comorbidities n (%)
 None 25 (32.5) 4 (22.2) 39 (50.6) 2 (25.0)
  > 1 52 (67.5) 14 (77.8) 38 (49.4) 6 (75.0)
Number of GP practice contacts (year prior inclusion) median (IQR) 7 (4.0;10.0) 7 (6.0;11.5) 6 (3.5;11.0) 9 (3.5;12.0)
GP years of working experience median (IQR) 17 (12.0;25.5) 17 (11.8;21.0) 16 (10.5;24.5) 18 (13.0;26.0)
GP setting n (%)
 Urban2 51 (66.2) 10 (55.6) 45 (58.4) 6 (75.0)
 Between rural and urban3 14 (18.2) 3 (16.7) 15 (19.5) 2 (25.0)
 Rural4 12 (15.6) 5 (27.8) 17 (22.1)

1Stage based on TNM classifications, 21000 or more addresses per km^2, 31000–1500 addresses per km^2, 41000 or less addresses per km^2

Abbreviations: SD Standard deviation, IQR Inter quartile range